ES2316501T3 - Moleculas marcadoras asociadas con tumores pulmonares. - Google Patents

Moleculas marcadoras asociadas con tumores pulmonares. Download PDF

Info

Publication number
ES2316501T3
ES2316501T3 ES02010275T ES02010275T ES2316501T3 ES 2316501 T3 ES2316501 T3 ES 2316501T3 ES 02010275 T ES02010275 T ES 02010275T ES 02010275 T ES02010275 T ES 02010275T ES 2316501 T3 ES2316501 T3 ES 2316501T3
Authority
ES
Spain
Prior art keywords
polypeptide
nucleic acid
luma1
cells
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02010275T
Other languages
English (en)
Spanish (es)
Inventor
Johannes Coy
Rainer Hipfel
Birgit Wasser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche MTM Laboratories AG
Original Assignee
Roche MTM Laboratories AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche MTM Laboratories AG filed Critical Roche MTM Laboratories AG
Application granted granted Critical
Publication of ES2316501T3 publication Critical patent/ES2316501T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
ES02010275T 2002-05-21 2002-05-21 Moleculas marcadoras asociadas con tumores pulmonares. Expired - Lifetime ES2316501T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20020010275 EP1365032B1 (en) 2002-05-21 2002-05-21 Marker molecules associated with lung tumors

Publications (1)

Publication Number Publication Date
ES2316501T3 true ES2316501T3 (es) 2009-04-16

Family

ID=29286116

Family Applications (2)

Application Number Title Priority Date Filing Date
ES02010275T Expired - Lifetime ES2316501T3 (es) 2002-05-21 2002-05-21 Moleculas marcadoras asociadas con tumores pulmonares.
ES03735709T Expired - Lifetime ES2303595T3 (es) 2002-05-21 2003-05-16 Moleculas marcadoras asociadas con tumores pulmonares.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES03735709T Expired - Lifetime ES2303595T3 (es) 2002-05-21 2003-05-16 Moleculas marcadoras asociadas con tumores pulmonares.

Country Status (9)

Country Link
US (2) US7355025B2 (cg-RX-API-DMAC10.html)
EP (2) EP1365032B1 (cg-RX-API-DMAC10.html)
JP (2) JP4520848B2 (cg-RX-API-DMAC10.html)
AT (2) ATE414789T1 (cg-RX-API-DMAC10.html)
AU (1) AU2003238077A1 (cg-RX-API-DMAC10.html)
CA (1) CA2486583C (cg-RX-API-DMAC10.html)
DE (2) DE60229920D1 (cg-RX-API-DMAC10.html)
ES (2) ES2316501T3 (cg-RX-API-DMAC10.html)
WO (1) WO2003097871A2 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11927591B2 (en) 2016-08-02 2024-03-12 Georgetown University Methods of identifying novel proteins and antigens in cancer cells
EP4010481A4 (en) 2019-08-09 2023-09-20 Nutcracker Therapeutics, Inc. MICROFLUIDIC DEVICE AND METHODS OF USE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US6316208B1 (en) * 1994-01-07 2001-11-13 Memorial Sloan-Kettering Cancer Center Methods for determining isolated p27 protein levels and uses thereof
US6033847A (en) * 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
CA2378512A1 (en) * 1999-06-16 2000-12-21 The Johns Hopkins University Characterization of the yeast transcriptome
US6806254B2 (en) * 2000-02-03 2004-10-19 Nuvelo, Inc. Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
AU2001241656A1 (en) * 2000-02-17 2001-08-27 Diadexus, Inc. Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2001250572A1 (en) * 2000-04-07 2001-10-23 Epigenomics Ag Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations
WO2002006294A2 (en) * 2000-07-13 2002-01-24 Genaissance Pharmaceuticals, Inc. Haplotypes of the mmp13 gene

Also Published As

Publication number Publication date
US7355025B2 (en) 2008-04-08
WO2003097871A8 (en) 2004-03-04
AU2003238077A8 (en) 2003-12-02
JP2010017194A (ja) 2010-01-28
EP1506317A2 (en) 2005-02-16
US20050176930A1 (en) 2005-08-11
AU2003238077A1 (en) 2003-12-02
EP1365032A1 (en) 2003-11-26
US20090098544A1 (en) 2009-04-16
ATE389033T1 (de) 2008-03-15
CA2486583A1 (en) 2003-11-27
DE60319693T2 (de) 2009-03-05
WO2003097871A3 (en) 2004-02-05
EP1506317B1 (en) 2008-03-12
US7883896B2 (en) 2011-02-08
DE60319693D1 (de) 2008-04-24
CA2486583C (en) 2013-09-24
EP1365032B1 (en) 2008-11-19
JP2005525826A (ja) 2005-09-02
WO2003097871A2 (en) 2003-11-27
DE60229920D1 (de) 2009-01-02
JP4520848B2 (ja) 2010-08-11
ES2303595T3 (es) 2008-08-16
ATE414789T1 (de) 2008-12-15

Similar Documents

Publication Publication Date Title
ES2277432T3 (es) Compuestos y metodos para terapia y diagnosis de cancer de pulmon.
EP1581641A2 (en) Compositions, splice variants and methods relating to ovarian specific genes and proteins
ES2286201T3 (es) Compuestos y procedimientos para la deteccion de carcinomas y sus lesiones precursoras.
JP2010239970A (ja) 乳癌の処置および診断のための組成物ならびにそれらの使用方法
ES2688186T3 (es) Productos génicos de expresión diferencial en tumores y su uso
ES2424976T3 (es) Isoformas relativas al cáncer de componentes de complejos de factores de transcripción como biomarcadores y dianas de fármacos
JP2002540789A5 (cg-RX-API-DMAC10.html)
ES2279877T3 (es) Polinucleotido utilizable para modular la proliferacion de celulas cancerigenas.
PT1290028E (pt) Um gene que codifica um homólogo de glicoproteína p humana de resistência a múltiplos fármacos, situado no cromossoma 7p15-21 e suas utilizações
WO2005017102A2 (en) Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
ES2303595T3 (es) Moleculas marcadoras asociadas con tumores pulmonares.
ES2298304T3 (es) Composiciones y procedimientos para la deteccion y tratamiento de anormalidades proliferativas asociadas con la sobreexpresion de gen like-1 de transcetolasa humano.
US20030175715A1 (en) Compositions and methods relating to breast specific genes and proteins
ES2350041T3 (es) Composiciones y métodos para la terapia y diagnóstico del cáncer de ovarios.
US20060078913A1 (en) Compositions, splice variants and methods relating to cancer specific genes and proteins
EP1365030A1 (en) G-protein coupled receptor marker molecules associated with colorectal lesions
US20020132255A1 (en) Compositions and methods relating to breast specific genes and proteins
US20020164344A1 (en) Compositions and methods relating to colon specific genes and proteins
WO2004052290A2 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
US20020150924A1 (en) Compositions and methods relating to prostate specific genes and proteins
ES2315296T3 (es) Composiciones para la terapia uy el diagnostico del cancer ovarico.
JP2009195236A (ja) 乳癌の免疫療法および診断のための化合物ならびにそれらの使用のための方法
US20050079515A1 (en) Compositions, splice variants and methods relating to breast specific nucleic acids and proteins
WO2005044075A2 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
WO2004050900A2 (en) Compositions, splice variants and methods relating to colon specific genes and proteins